Healthcare -
Biotechnology - NASDAQ - US
$ 15.11
1.96 %
$ 614 M
Market Cap
-88.88
P/E
KROS - REVENUE
Revenue KROS - Keros Therapeutics, Inc.
3.55 M
LAST VALUE
0.00%
2 YEAR CAGR
-18.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR